Avient Corporation — Form 8-K Summary
Reporting date: October 7, 2026; the report was signed and the related press release was issued October 9, 2026. The filing covers a leadership transition and a reaffirmation of third-quarter and full-year 2026 guidance.
Financial performance and outlook
- Avient reaffirmed its previously issued third-quarter and full-year 2026 financial guidance, originally provided August 6, 2026. The filing text does not provide the guidance figures.
- Third-quarter closing procedures were ongoing. Actual results could differ from preliminary expectations and remained subject to normal quarter-end and reporting processes.
- The filing provides no reported revenue, earnings, cash flow, margins, debt, liquidity, or other operating results, and no clear figures for comparison with the prior period.
Leadership transition and compensation
- Effective October 7, 2026, the Board appointed Michael J. Frank President and Chief Executive Officer and a director. He succeeds Dr. Ashish K. Khandpur, who will provide advisory support through 2026. Frank was also appointed to the Board’s Innovation and Sustainability Committee.
- Frank’s annual base salary is $1,222,000. His annual cash incentive target is 120% of earned base salary, with a potential payout of 0% to 200% of target, prorated for 2026. His 2027 long-term equity incentive target is 510% of annual base salary.
- Sign-on compensation includes $1.6 million in cash, repayable if Frank voluntarily resigns or is terminated for cause within 12 months; restricted stock units valued at approximately $5 million, vesting over five years; and cash-settled performance units with an approximately $11.4 million target value. Performance-unit payouts range from 0% to 200% of target based on adjusted EPS (67%) and relative total shareholder return (33%) over 2026–2028.
- Frank may generally receive two years of salary continuation and specified benefits if terminated without cause, subject to conditions. A change-in-control agreement is expected to provide benefits in qualifying circumstances within 24 months after a change in control.
- Khandpur is entitled to specified severance benefits subject to plan conditions, including two years of salary continuation and subsidized medical, dental, and vision coverage. His 2026 equity awards will be prorated; other outstanding awards are forfeited. In exchange for his resignation from the Board, advisory support, and extended restrictive covenants, 38,047 outstanding RSUs are scheduled to vest December 1, 2026, and 38,046 on December 1, 2027.
Risks, contingencies, and items to verify
- Verify the actual third-quarter results and the specific 2026 guidance figures when reported; this filing only states that guidance was reaffirmed and results were not final.
- Review the subsequent reporting for any changes to guidance after completion of quarter-end procedures.
- Verify the final terms and execution of Frank’s expected change-in-control and other agreements, and the conditions governing severance and sign-on compensation.
- Track the performance conditions, vesting, and eventual payout of Frank’s equity and performance awards, as well as the scheduled vesting of Khandpur’s RSUs.